| Outcome Measures: |
Primary: ACR(Urine Albumin/Creatinine ratio), change of percentage, treatment period(24 weeks) | Secondary: ACR(Urine Albumin/Creatinine ratio), improvement efficiency rate of ACR comparing to baseline Definition of improvement efficiency : ACR become normal(\<20mg/g Cr) or ACR is decreased more than 50% comparing to data before taking IP(Investigators' product), Treatment period(24 weeks)|urinary 5-HIAA(5-Hydroxyindoleacetic acid), type 4 collagen, changes comparing to baseline data, treatment period(24 weeks)|ACR(Urine Albumin/Creatinine ratio), improved amount comparing to baseline data, treatment period(24 weeks)|ACR(Urine Albumin/Creatinine ratio), rate of normalized ACR, treatment period(24 weeks)|Creatinine, improved amount of Creatinine, treatment period(24 weeks)|PCR(Protein to Creatinine ratio in Urine), improved rate comparing to baseline data, treatment period(24 weeks)
|
